CALGENE APPOINTS VICE PRESIDENT FOR RESEARCH
CALGENE APPOINTS VICE PRESIDENT FOR RESEARCH DAVIS, Calif., Nov. 8 /PRNewswire/ -- Calgene Inc. (NASDAQ: CGNE)
announced today that Dr. Vic Knauf has been promoted to vice president for Research. He was previously the Oilseeds Division research director.
Knauf joined Calgene in February 1983 after receiving his doctorate in microbiology and immunology at the University of Washington. He has had primary responsibilities over the last seven years for managing the plant oil modification research program, the largest research effort at Calgene. Under Knauf's leadership, Calgene scientists have established a clear technical lead in plant oil modification. Calgene was the first to express a gene specifically in seeds of a major oilseed crop, the first to clone a commercially important plant gene involved in oil synthesis and the first to modify oil composition in rapeseed, a major oilseed crop. Roger Salquist, Calgene's chief executive officer, said, "Dr. Knauf has demonstrated uncommon tenacity and commitment in leading the Calgene oils research team to the string of breakthroughs and successes. He has the ability to build consensus and to make tough and timely decisions. The Calgene research and development organization has accomplished more than any of our competitors in this field in the past five years and this promotion is recognition of that fact." Don Helinski, Ph.D., chairman of Calgene's Science Advisory Council and director of the Center for Molecular Genetics at the University of California, San Diego, said, "Dr. Knauf has clearly established himself as a scientific leader who not only has made outstanding scientific contributions to Calgene's oil modification program but he has shown the vision and scientific managerial skills that are necessary to sustain Calgene's leadership in plant biotechnology. The appointment of Vic as vice president for research has the full and enthusiastic support of Calgene's scientific advisors." Calgene has invested over $80 million in research and development since its inception in 1980. Currently, Calgene employs 120 research and support staff and has research and development expenditures of approximately $13 million annually. The company focuses its research on three core crops -- tomato, cotton and rapeseed. In 1991 the company was the first to file with the FDA a genetically engineered food, its FLAVR SAVR(TM) tomato. It recently completed the largest engineered field trial ever with its 34 location Bromotol(TM) safened cotton conducted in 12 states. In October Calgene received approval from the USDA to conduct the world's first field tests of canola genetically engineered to produce a modified vegetable oil. Calgene is an agribusiness biotechnology company that is developing improved plant varieties and plant products for the seed, food and specialty chemical industries. The company has three operating subsidiaries -- Ameri-Can Pedigreed Seed Co., Calgene Chemical and Stoneville Pedigreed Seed Co. -0- 11/8/91 /CONTACT: Daniel Wagster of Calgene Inc. 916-753-6313/ (CGNE) CO: Calgene Inc. ST: Californis IN: FOD SU: PER DB -- SF001 -- 2462 11/08/91 08:01 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 8, 1991|
|Previous Article:||TAB DECLARES CASH DIVIDEND|
|Next Article:||SKYWEST INC. REPORTS SECOND QUARTER RESULTS|